New UNAIDS Data on HIV Response During COVID-19

The data from UNAIDS of the global HIV response has shown that progress has faltered and resources have shrunk during the last two years of COVID-19 and other global crises.

As a result, millions of lives are now at risk. Communities that were already at a greater risk of HIV are now even more vulnerable due to an increase of 75 to 95 million people being pushed into poverty.

The data shows that the progress against HIV is slowing, with the smallest drop in new HIV cases being reported in 2020 since 2016.

 

 

The report also shows how UNAIDS responded to the unjust war in the Ukraine, with US$ 250 000 being disbursed to preserve key HIV services.

 

Read the full report here.

Office for National Statistics publish new figures on drug-related deaths in England and Wales for 2021

The Office for National Statistics have published new figures on drug-related deaths in England and Wales for 2021, revealing another increase in drug-related deaths.

 

According to the report, 4,859 people died from drug poisoning in 2021. Drug related deaths have risen by 85th since 2012; this marks the ninth consecutive year of drug related deaths rising.

Around half the deaths involved opiates (2,219), with cocaine related deaths rising by over 8%.

“Measures which have reversed drug related deaths in other parts of the world need to be considered as a way to stop people dying and promote harm reduction. Overdose Prevention Centres, of which there are over 200 in many countries across the world including Switzerland, Germany and the USA are an undoubtedly proven way of doing just this.”

Overdose Prevention Centres are named as being a critical way of reducing thousands of avoidable drug-related deaths. Unified public services, community-based interventions, outreach programs and drug support services were also named as methods which require more funding.

Read the full article here.

Updates from the AIDS 2022 Conference

The AIDS2022 conference is taking place in Montreal, with experts in the field of HIV/AIDS sharing knowledge and experience related to the virus.

Advocation for people who use drugs was present during the conference, with the stigma and judgement faced by people who inject drugs being addressed as barriers to seeking care; it was reinforced that everyone should be able to access affordable, quality care irrespective of their drug use status. Virginia Macdonald of the World Health Organisation strongly recommended the implementation of needle & syringe exchange programs and overdose prevention care.

As well as this, activists demanded stronger action to be taken from the world health organization against Monkeypox, through urgent scaled up and equitable vaccine access. The activists emphasized lifting intellectual property barriers, and the need for a plan for prevention, treatment and care.

Click here for more information on the conference.

Civil Society Demands Balanced EU Funding for Drug Policies

Civil society organisations sent an open letter to the EU Commission to criticise the new call for drug policy grant proposals that almost only focuses on law enforcement and excludes harm reduction.

C-EHRN sent an open letter to Ilva Johanson, Commissioner of Home Affairs, and Floriana Sipala, the head of the Drug Unit of the EC, to address this issue. The text of the open letter:

“We write to you on behalf of Correlation – European Harm Reduction Network (C-
EHRN), representing 158 civil society organisations (CSO) working in the area of harmreduction drug policy in Europe. C-EHRN is part of Foundation De Regenboog Groep
and, as such, is also represented in the EU Civil Society Forum on Drugs.

Together with the undersigned networks, we would like to express our concern and
disappointment with the current call of the Internal Security Grant concerning better
law enforcement in the area of illicit drug trafficking. We believe this call does not
reflect the principles of an evidence-based, integrated, balanced and multidisciplinary
approach to the drugs phenomenon and is not in line with the Drug Strategy of the
European Union. The call has a narrow focus on law enforcement interventions, with
no objectives to improve complex public health and social services, including harm
reduction.

For several years, the members and organisations we work with have benefited from
the EC JUST Drug Policy grants launched by the European Commission. These
grants demonstrated the balanced, evidence-based and multidisciplinary approach
to drug policies in accordance with the core principles of the European Union. They
provided an excellent opportunity for civil society organisations working in the field of
drugs to cooperate internationally and exchange knowledge and good practices.

When the Drugs Unit was moved from the Justice Department to the Internal Security
Department, civil society organisations were promised that this would not affect the
balanced and multidisciplinary approach to drug policies of the EU Commission.
However, the apparent shift towards law enforcement and crime prevention proves
different – with social and public health aspects slipping off the agenda.

The Internal Security call lays only limited emphasis on drug demand reduction and
none at all on harm reduction. At the same time, no other EU Programme took over
this responsibility, leaving drug demand and harm reduction behind, without any
opportunity for EU funding and support.

This is an extremely concerning development. EU funding has become increasingly
important in recent years because of the emerging funding crisis for harm reduction,
especially in the Eastern part of the European Union. Since the 2008 economic crisis,
funding for harm reduction has constantly been declining in most Member States.
Several essential services operated by CSOs have been closed down or curtailed due
to budget cuts and the retreat of international donors.

On top of the funding crisis, CSOs experience a shrinking space for civil society in
several Member States, where governments are increasingly hostile to those
organisations that receive international funding or work with marginalised groups of society. With decreasing national and local funds, direct funding from the European
Commission was often the only funding opportunity to improve advocacy and
innovation in the harm reduction field for many organisations. This opportunity is now
lost.

DG Home is the department within the EC responsible for developing and
implementing a balanced, integrated and evidence-based EU Drug Policy. Such a
balanced approach requires that funding mechanisms are available for all drug policy
areas and not only for law enforcement and crime prevention programmes.
We, therefore, call upon the European Commission and DG Home to reinstall the
funding mechanism for drug demand and harm reduction to ensure a balanced and
evidence-based drug policy also in the future.

We look forward to your response and hope for your continued support for civil
society in the area of drug policy and harm reduction.”

Signatory Networks & Organizations:
AIDS Action Europe [AAE]
Drug Policy Network South East Europe [DPNSEE]
EU Civil Society Forum on Drugs1
EU HIV/AIDS, Viral Hepatitis and Tuberculosis Civil Society Forum
Eurasian Harm Reduction Association [EHRA]
European AIDS Treatment Group [EATG]
European Network of People Who Use Drugs [EuroNPUD]
Forum Droghe
Harm Reduction International [HRI]
Federation des Acteurs en Education en Promotion de la Sante de Guyane [AGRRR]
International Drug Policy Consortium [IDPC]
International Network of People Who Use Drugs [INPUD]
MAINline
Positive Voice
Red de Atencion a las Adicciones [UNAD]
ReShape
Youth Organizations for Drug Actions [YODA]

Open Call: C-EHRN Expert Groups & Consultations

As part of our 2022 work plan, C-EHRN is working with different Expert Groups and will organize consultations addressing a variety of topics. With this open call, C-EHRN would like to invite all its members and partners to engage and participate in these Expert Groups and Consultations based on their interest and expertise in any of the following areas:

  1. Hepatitis & Drug Use
  2. Coverage of Harm Reduction in Europe
  3. New Drug Trends
  4. National Harm Reduction Networks
  5. Harm Reduction in Prison and other Custody Settings
  6. Integrated & People-centred Care Models
  7. Community-based & Community-led Research

If you wish to participate, we invite you to express your interest and share a brief description of your area of expertise [max. 100 words] through the following email: administration@correlation-net.org before the 31st of July 2022.

Register for Webinar on State & Challenges of Overdose Prevention

Monitoring and evaluation of harm reduction services and policies, helps to improve the access of and quality of care for people who use drugs. Our next webinar will discuss the recent monitoring data relating to the State and Challenges of Overdose Prevention, on 13th July at 4PM.

This webinar will present the C-EHRN Monitoring Data Report 2021 key findings in the field of Overdose Prevention and discuss them with representatives from different European organizations and institutions.
Programme:
4:00 PM   Welcome and Introduction | Katrin Schiffer [C-EHRN]
4:05 PM   Key findings of the Monitoring Report on Overdose Prevention – Rafaela Rigoni (C-EHRN)
4:20 PM  Panel Discussion | Adriana Curado [GAT], Aljona Kurbatova [TAI], Dirk Schaeffer, Marios Aztemis [Positive Voice], Rafaela Rigoni [C-EHRN]. Moderator: Katrin Schiffer (C-EHRN)
5:00 PM  Conclusions and closing | Katrin Schiffer [C-EHRN]

 

Register here 

Hepatitis C and Drug Use Monitoring Webinar Recording

On behalf of C-EHRN and all the individuals and organisations that made the Monitoring Data Report 2021 possible, we are excited to share the webinar recording with you, it can be viewed through the link below;
 
 
https://youtu.be/2kpziFcnnu4
 
 
We would like to express special thanks to Rafaela Rigoni [C-EHRN] for moderating the webinar, and to the fantastic panelists; Tukka Tammi [THL], Mojca Maticic [professor at University Medical Centre Ljubljana and EASL member], Tessa Windelinckx [Free Clinic and C-EHRN FP] and Martin Kåberg [Stockholm Center for Dependency Disorders and Stockholm NSPs].
 
The full monitoring report can be accessed through the link below:
 https://www.correlation-net.org/wp-content/uploads/2022/05/MONITORING-OF-HARM-REDUCTION-IN-EUROPE-2021_web.pdf
 
 
The next webinar in this series is on the State and Challenges of Overdose Prevention, and will take place on 13th July at 16:00PM (CET). Register through the link below;
https://us02web.zoom.us/webinar/register/WN_SJf50wxNSf2uYAaHOFHbvw
 
 
Again, we would like to thank everyone involved in the process of this monitoring report, and everyone who took part in the webinar.
 
 
We hope to see you again at our future events, if you have any questions regarding the webinar, please feel free to contact monitoring@correlation-net.org

New Steering Committee Members

We are happy to announce the New Steering Committee members!

Based on the results of the voting process and the specific profiles developed for this selection process, the following candidates have been elected: Tony Duffin, Daan van der Gouwe, Roisin Downes and Perrine Roux.

Also, C-EHRN would like to take the opportunity to thank all the members that submitted an application. Also, to emphasize the high level of expertise and the excellent applications received for this election.

 

In the coming days, the newly elected members will participate in its first Steering Committee Meeting. In this event, they will have the opportunity to meet the current remaining members and to connect with those who leave their seats.

C-EHRN would like to invite you all to join us in congratulating the four new committee members. We are truly excited to start working with them!

Request for Proposals

As part of an Operating Grant for our activities in 2022, C-EHRN is looking for different
experts and consultants and strongly encourages professionals within the Network to
submit proposals. Due to funding regulations, we specifically invite candidates from the
EU Member States, whose GNI per inhabitant is less than 90% of the EU average.

SPECIFIC OBJECTIVES OF THE CONSULTANCY
1. To conduct a scoping review of current literature and methodological guidelines for the
development of community-based and community-led research.
2. To collect and analyse good practice examples (at least 5 cases) of community-based
and/or community-led research projects in the field of harm reduction and drug use,
preferably in the European context
3. To organise an online consultation/focus group with experts in the field to assess
critical factors for the development and implementation of community-based and
community-led research
4. To conduct interviews with selected experts in the field to complement desk research
for points 1 and 2.
5. To prepare a report (20 to 30 pages) and a policy brief with recommendations (3 to 5
pages) based on the outcomes of the online consultation, the good practice examples
collection and the literature review.
6. To participate in the C-EHRN Expert meeting, to present and discuss preliminary
findings and collect additional input for the report.

HOW TO APPLY
To be eligible as a consultant, individuals must comply with C-EHRN’s Mission and Vision,
which you can find at the following link:
https://www.correlation-net.org/mission/
.Applicants must submit a short letter of interest and a CV. These documents should
reflect the candidate’s competency to complete the consultancy, including references to
the requested skills, knowledge and professional experience.
Please, submit this information to administration@correlation-net.org until the 27th of
May 2022, 23:59 CET. In the subject line of your e-mail, please indicate the Reference
Number, the title of the Consultancy and your name:
Reference Number | Consultancy Title | Name & Family Name
Note: if these documents are not submitted in full, the application will not be considered.

MORE INFORMATION
For more information, contact administration@correlation-net.org.

View the full call for proposals here

Online Webinars 2022

Correlation – European Harm Reduction Network is excited to invite you to the online webinar series of its Civil Society Monitoring of Harm Reduction in Europe in 2021. In the coming months, we would like to invite you to join us in discussing the main key findings of our Data Report 2021 in a series of dialogues with harm reduction professionals, policymakers, researchers and European agencies, among others:

Webinar 01 | Launch Monitoring Report 2021
11th of May 16:00h – 16:45h

Webinar 02 | Hepatitis C & Drug Use
15th of June 16:00h – 17:00h

Webinar 03 | State & Challenges of Overdose Prevention 
13th of July 16:00h – 17:00h

Webinar 04COVID-19 Impacts on Harm Reduction
14th of September 16:00h – 17:00h

Webinar 05 | Monitoring New Drugs Trends
12th of October 16:00h – 17:00h